Combined inhibition of mTORC1 with temsirolimus and HER2 with neratinib: A phase I/II study in patients with metastatic HER2-amplified or triple-negative breast cancer Meeting Abstract


Authors: Gajria, D.; King, T.; Pannu, H.; Sakr, R.; Seidman, A. D.; Modi, S.; Dickler, M.; Drullinsky, P.; Syldor, A.; Sujata, P.; Majid, M.; Norton, L.; Rosen, N.; Chandarlapaty, S.
Abstract Title: Combined inhibition of mTORC1 with temsirolimus and HER2 with neratinib: A phase I/II study in patients with metastatic HER2-amplified or triple-negative breast cancer
Meeting Title: 34th Annual CTRC-AACR San Antonio Breast Cancer Symposium (SABCS)
Journal Title: Cancer Research
Volume: 71
Issue: 24 Suppl.
Meeting Dates: 2011 Dec 6-10
Meeting Location: San Antonio, TX
ISSN: 0008-5472
Publisher: American Association for Cancer Research  
Date Published: 2011-12-01
Language: English
ACCESSION: WOS:000209699800096
DOI: 10.1158/0008-5472.SABCS11-PD09-08
PROVIDER: wos
Notes: Meeting Abstract: PD09-08 -- Source: Wos
Altmetric Score
MSK Authors
  1. Andrew D Seidman
    244 Seidman
  2. Larry Norton
    562 Norton
  3. Neal Rosen
    359 Rosen
  4. Maura N Dickler
    237 Dickler
  5. Nancy S Rosen
    27 Rosen
  6. Harpreet Pannu
    20 Pannu
  7. Tari King
    165 King
  8. Devika Gajria
    23 Gajria
  9. Shanu Modi
    132 Modi
  10. Rita Sakr
    59 Sakr
  11. Angemael   Syldor
    4 Syldor